Trials / Completed
CompletedNCT00575354
Comparison of Sevoflurane and Isoflurane Anesthesia for Benign Breast Tumor Excision
Anesthesia With Sevoflurane and Isoflurane for Excision Surgeries in Benign Breast Tumors
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Nanjing Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
Generally, benign breast tumors are excised under the local anesthesia. But such action was so invasive that every patient would experience the physiological and psychological stimuli unavoidably. Sevoflurane was advised as a better inhalational anesthesic for its "easy come,easy go" property during short-lasting operations than isoflurane. We purposed that sevoflurane would be a superior anesthesic for benign breast tumor excision than isoflurane with relative less alteration in hemodynamics, less postoperative side effects and easily-control the depth of anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sevoflurane | 3-6% sevoflurane inhaled for anesthesia induction, and 2-3% sevoflurane was used to maintain the anesthesia till the end of the operation. |
| DRUG | Isoflurane | 3-6% isoflurane inhaled for anesthesia induction, and 2-3% isoflurane was used to maintain the anesthesia till the end of the operation. |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2007-12-18
- Last updated
- 2008-04-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00575354. Inclusion in this directory is not an endorsement.